Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


16.04.2018

2 Arch Virol
1 J Infect Dis
2 J Virol
1 Lancet
2 Lancet Respir Med
2 PLoS One
2 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. HOSSAN MS, Fatima A, Rahmatullah M, Khoo TJ, et al
    Antiviral activity of Embelia ribes Burm. f. against influenza virus in vitro.
    Arch Virol. 2018 Apr 10. pii: 10.1007/s00705-018-3842.
    PubMed     Text format     Abstract available

  2. NEROME K, Shimizu K, Zukeran S, Igarashi Y, et al
    Functional growth inhibition of influenza A and B viruses by liquid and powder components of leaves from the subtropical plant Melia azedarach L.
    Arch Virol. 2018 Apr 9. pii: 10.1007/s00705-018-3830.
    PubMed     Text format     Abstract available


    J Infect Dis

  3. WANG Y, Guo Q, Yan Z, Zhou D, et al
    Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection.
    J Infect Dis. 2018 Apr 10. pii: 4965883. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  4. NIEMEYER BF, Oko LM, Medina EM, Oldenburg DG, et al
    Host Tumor Suppressor p18(INK4c) Functions as a Potent Cell-Intrinsic Inhibitor of Murine Gammaherpesvirus 68 Reactivation and Pathogenesis.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available

  5. BAE JY, Lee I, Kim JI, Park S, et al
    A Single Amino Acid at the Polymerase Acidic Protein Determines the Pathogenicity of Influenza B Viruses.
    J Virol. 2018 Apr 11. pii: JVI.00259-18. doi: 10.1128/JVI.00259.
    PubMed     Text format     Abstract available


    Lancet

  6. GREEN A
    Progress in influenza surveillance in Africa.
    Lancet. 2018;391:1345-1346.
    PubMed     Text format    


    Lancet Respir Med

  7. VESIKARI T, Kirstein J, Devota Go G, Leav B, et al
    Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Lancet Respir Med. 2018 Apr 6. pii: S2213-2600(18)30108.
    PubMed     Text format     Abstract available

  8. NEUZIL KM, Rotrosen ET
    How do we best prevent influenza in young children?
    Lancet Respir Med. 2018 Apr 6. pii: S2213-2600(18)30138.
    PubMed     Text format    


    PLoS One

  9. WANG J, Hilchey SP, DeDiego M, Perry S, et al
    Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.
    PLoS One. 2018;13:e0193680.
    PubMed     Text format     Abstract available

  10. LEE N, Khalenkov AM, Lugovtsev VY, Ireland DD, et al
    The use of plant lectins to regulate H1N1 influenza A virus receptor binding activity.
    PLoS One. 2018;13:e0195525.
    PubMed     Text format     Abstract available


    Vaccine

  11. HOFFMANN A, Dumke C, Hanschmann KO, Wicker S, et al
    Local thermal reaction after influenza vaccination: Quantification by infrared imaging and biometric considerations.
    Vaccine. 2018 Apr 10. pii: S0264-410X(18)30467.
    PubMed     Text format     Abstract available

  12. LAPUENTE D, Ruzsics Z, Thirion C, Tenbusch M, et al
    Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30262.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: